Robeco Institutional Asset Management B.V. Taro Pharmaceutical Industries LTD Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$54.4 - $73.42 $422,416 - $570,106	-7,765 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$61.66 - $70.16 $506,906 - $576,785	-8,221 Reduced 51.43%	7,765 $516,000
Q4 2019 Feb 06, 2020	SELL	$74.18 - $97.92 $2.78 Million - $3.67 Million	-37,455 Reduced 70.09%	15,986 $1.41 Million
Q2 2019 Jul 19, 2019	BUY	$83.92 - $108.88 $1.68 Million - $2.18 Million	20,002 Added 59.82%	53,441 $4.56 Million
Q1 2019 May 02, 2019	SELL	$85.97 - $108.09 $108,838 - $136,841	-1,266 Reduced 3.65%	33,439 $3.61 Million
Q4 2018 Feb 08, 2019	SELL	$78.25 - $107.92 $116,983 - $161,340	-1,495 Reduced 4.13%	34,705 $2.94 Million
Q3 2018 Oct 31, 2018	BUY	$97.82 - $116.09 $296,394 - $351,752	3,030 Added 9.13%	36,200 $3.56 Million
Q2 2018 Aug 03, 2018	BUY	$97.62 - $120.59 $3.24 Million - $4 Million	33,170 New	33,170 $3.84 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account